The landscape of obesity treatment is rapidly evolving with the emergence of several promising injectable therapies. the GLP-1/GIP dual agonist, a peptide with multiple actions, a GLP-1/GIP/GCG triple agonist , https://nexaphresearchpeptides.com/product-category/research-products/